No ratings

Hope you're week's treating all of you well. While we continue to get more upside in equities, we got more good news this morning from a few of our featured stocks, and if what's starting to develop with a number of our smaller penny plays starts to pan out, we could be looking at some pretty big gains very soon.

First, scientists are often not the best communicators, and definitely aren't the best sales people. At least not like the Mark Cubans of the world, who always seem to know how to say the right things at the right time, and equally as important know how to get the masses to understand and buy into a message.

No ratings

If yesterday's preliminary release of information on Azincourt Uranium, Inc. (AZURF) wasn't enough to get speculative investors' mouths watering as one potentially promising junior uranium miner, maybe this morning's news will.

We explained yesterday all of the details surrounding the history and future potential of the Athabasca Basin, a region in the Canadian Shield of northern Saskatchewan and Alberta Canada, which has for years produced the highest uranium grades in the world. The Basin, as it is commonly known, provides nearly 20% of the world's high grade uranium and has an average grade of 2% (ten times higher than the world average).

No ratings

How does the old saying go? Expect it when you least expect it? It's painfully cliche, but that doesn't mean it's bad advice. In fact, it's good advice even for investors... especially for investors. Just when you think something's a foregone conclusion, everything changes.

That's the crux of today's idea. Nobody saw it coming, but it's here, and this stock is up 250% since the beginning of the year because of this tidal shift. Don't worry though. We think there's plenty more upside left to go.

No ratings

Did everybody see what happened with Staffing 360 Solutions (STAF) today? If not, here's the Q&D version - Jackson Investment Group is interested in acquiring the company, sending STAF shares up about 46% when all was said and done. Thing is, Staffing 360 Solutions is easily worth more than the offer, and could very likely counter-offer at an even much better price (and Jackson would still be getting a bargain).

We thought that might catch your attention. It certainly caught ours.

No ratings

Good morning everyone. As promised in Wednesday afternoon's newsletter, we've got another trading idea for you today... one with a heap of upside potential as far as we're concerned. It comes from the medical-technology space, where a company's size is irrelevant - it's all about the performance of the product. In short, this company can effectively take a 3D picture of your entire heart, giving caregivers so much more information than a 2D image or even a series of 2D images can.

The company in question is called Ventripoint Diagnostics (VPTDF, CVE:VPT). It's possible you've heard of it, though not likely; it's been laying low for a while. Be sure to put it on your radar/watchlist though. See, something happened in early March that quietly set the stage for what could be a very exciting 2017 for VPTDF shareholders.

We'll concede right up front we're not going to be able to do Ventripoint's technology its due justice in the limited time and space we have in the newsletter. We'll hit the highlights, and refer you to the company's website for the details many of you biotech aficionados crave. It would be time well spent for any current or potential VentriPoint Diagnostics shareholders to visit the company's website, however, as it's got some amazing stuff going on.